Using Data and R to Deliver Evidence-Based Care for Substance Use Disorders by Asmae Toumi Visit https://rstats.ai/nyr/ to learn more. Abstract: The deaths from the U.S. opioid epidemic have reached a new record, totaling 108,000 in 2021 according to the CDC. The number of drug overdose has quadrupled since 1999. Curbing this unrelenting crisis is at the heart of many interventions by the government, public health experts, providers and community activists. PursueCare is a company offering comprehensive care for substance use disorders and other mental health conditions through telehealth technology and in-person treatments. Asmae Toumi, the director of analytics and research at PursueCare, will talk about how data and R/RStudio’s public and professional tools are being used to deliver evidence-based care and monitor outcomes. Bio: Asmae Toumi is the Director of Analytics and Research at PursueCare, a telehealth company specializing in treating substance use disorder and other mental health conditions. By night, she is the editor-in-chief of Hockey-Graphs, a hockey sports analytics blog. She recently won the 2021 NFL Big Data Bowl with her group Twitter: https://twitter.com/asmae_toumi Presented at the 2022 New York R Conference (June 10, 2022)